Shandong Xinhua Pharmaceutical Co Overview
- Founded
-
1943
- Status
-
Public
- Employees
-
6,540
- Stock Symbol
-
000756
- Share Price
-
$2.43
- (As of Wednesday Closing)
Shandong Xinhua Pharmaceutical Co General Information
Description
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
SHE
Primary Office
- No.1 Lutai Avenue, High-tech Zone
- Zibo, 255086
- China
+86 153 0000 0000
Shandong Xinhua Pharmaceutical Co Stock Performance
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.43 | $2.48 | $1.14 - $6.07 | $1.27B | 670M | 26.4M | $0.08 |
Shandong Xinhua Pharmaceutical Co Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 2,258,082 | 947,400 | 736,543 | 685,873 |
| Revenue | 1,032,822 | 1,015,951 | 869,290 | 811,333 |
| EBITDA | 139,007 | 139,365 | 122,574 | 112,558 |
| Net Income | 53,063 | 53,979 | 47,022 | 43,413 |
| Total Assets | 1,185,684 | 1,150,285 | 1,085,661 | 919,853 |
| Total Debt | 251,030 | 163,750 | 166,461 | 211,473 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Shandong Xinhua Pharmaceutical Co Patents
Shandong Xinhua Pharmaceutical Co Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10399931-B2 | Octahydroanthracene compound, preparation method and application thereof | Active | 20-Apr-2016 | 0000000000 | |
| US-20190071393-A1 | Octahydroanthracene compound, preparation method and application thereof | Active | 20-Apr-2016 | 0000000000 |
Shandong Xinhua Pharmaceutical Co Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Shandong Xinhua Pharmaceutical Co Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00000000 000000 00 | Distributors/Wholesale | South El Monte, CA | 0000 |